Common mutations in BC (including TP53, ERBB2, BRCA1, BRCA2, ATM, MUC16, PIK3CA, and PTEN) were analyzed to probe the potential influence in the expression of Key-TNBC-CRGs through the TIMER tool. This evidence concerns the gene ERBB2 and breast cancer.